The Australian Pancreatic Genome Initiative (APGI) is working to map the genetic blueprint of pancreatic cancer.
A comprehensive pancreatic cancer genomic databank will foster new and more effective ways to treat and manage pancreatic cancer for each individual cancer patient. This is the era of personalised medicine. Broadcast in April 2010.
The Australian discovery of two biomarkers that will help to determine the likely success of risky pancreatic cancer surgery.
The APGI is a member of the International Cancer Genome Consortium. The Australian contribution is pancreatic cancer and is co-led by the Garvan Institute in Sydney and the Institute of Molecular Bioscience in Brisbane. Our goal is to map the genome of pancreatic cancer in order to provide scientists and doctors tools to discover new ways to treat pancreatic cancer.
Professor Andrew Biankin talks about Garvan's work in pancreatic cancer.
Professor Andrew Biankin talks to the 7:30 Report about exciting new developments in pancreatic cancer research in Australia. Broadcast in April 2010.
This is a documentary on Avner Nahmani Pancreatic Cancer Foundation that details the human story behind the research and nursing work now being pursued. As the most lethal cancer, there is often too little that can be done once diagnosed. This story shows how, with the help of the growing community behind pancreatic cancer research, we are on track to double the survival rate by 2020. Written, produced and narrated by Amy Hosking.